Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Prostate Cancer | Research

Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer

Authors: Jingzhou Wang, Jie Liu, Chenggang Yuan, Bingqi Yang, Huai Pang, Keru Chen, Jiale Feng, Yuchun Deng, Xueting Zhang, Wei Li, Cuizhe Wang, Jianxin Xie, Jun Zhang

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Obesity-induced abnormal bone marrow microenvironment is one of the important risk element for bone metastasis in prostate cancer (PCa). The present study aimed to determine whether obesity-induced elevation in palmitic acid (PA), which is the most abundant of the free fatty acids (FFAs), increased CCL2 via the GPRs/KLF7 pathway in bone marrow adipocytes (BMA) to facilitate PCa growth and metastasis.

Methods

We constructed a bone-tumor bearing mouse model with obesity through high-fat diet, and observed the tumor formation ability of PCa cells. In vitro, observe the effect of PA on the expression level of CCL2 in BMA through GPRs/KLF7 signaling pathway. After co-culture of BMA and PCa cells, CCK8 assay and transwell experiment were used to detect the changes in biological behavior of PCa cells stimulated by BMA.

Results

The BMA distribution in the bone marrow cavity of BALB/c nude mice fed with the high-fat diet (HFD) was evidently higher than that in the mice fed with the normal diet (ND). Moreover, HFD-induced obesity promoted KLF7/CCL2 expression in BMA and PCa cell growth in the bone marrow cavity of the mice. In the vitro experiment, a conditioned medium with increased CCL2 obtained from the BMA cultured with PA (CM-BMA-PA) was used for culturing the PCa cell lines, which evidently enhanced the proliferation, invasion, and migration ability. KLF7 significantly increased the CCL2 expression and secretion levels in BMA by targeting the promoter region of the CCL2 gene. In addition, GPR40/120 engaged in the PA-induced high KLF7/CCL2 levels in BMA to facilitate the malignant progression of PC-3 cells.

Conclusions

PA-activated GPRs/KLF7/CCL2 pathway in BMA facilitates prostate cancer growth and metastasis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hsieh TF, Chen HL, Hsia YF, Lin CC, Chiang HY, Wu MY, Chen SH, Hsieh PF, Wu HC, Chang H, Kuo CC. Age-specific percentile-based prostate-specific antigen cutoff values predict the risk of prostate cancer: A single hospital observation. Biomedicine (Taipei). 2023;13(3):9–24.PubMedCrossRef Hsieh TF, Chen HL, Hsia YF, Lin CC, Chiang HY, Wu MY, Chen SH, Hsieh PF, Wu HC, Chang H, Kuo CC. Age-specific percentile-based prostate-specific antigen cutoff values predict the risk of prostate cancer: A single hospital observation. Biomedicine (Taipei). 2023;13(3):9–24.PubMedCrossRef
2.
go back to reference Wong MCS, Goggins WB, Wang HHX, Fung FDH, Leung C, Wong SYS, Ng CF, Sung JJY. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol. 2016;70(5):862–74.PubMedCrossRef Wong MCS, Goggins WB, Wang HHX, Fung FDH, Leung C, Wong SYS, Ng CF, Sung JJY. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol. 2016;70(5):862–74.PubMedCrossRef
3.
go back to reference Kimura T, Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018;25(6):524–31.PubMedCrossRef Kimura T, Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018;25(6):524–31.PubMedCrossRef
4.
go back to reference Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.PubMedCrossRef Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.PubMedCrossRef
5.
go back to reference Choi SY, Jeon JM, Na AY, Kwon OK, Bang IH, Ha YS, Bae EJ, Park BH, Lee EH, Kwon TG, Lee JN, Lee S. SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines. Cancer Genomics Proteomics. 2022;19(1):50–9.PubMedPubMedCentralCrossRef Choi SY, Jeon JM, Na AY, Kwon OK, Bang IH, Ha YS, Bae EJ, Park BH, Lee EH, Kwon TG, Lee JN, Lee S. SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines. Cancer Genomics Proteomics. 2022;19(1):50–9.PubMedPubMedCentralCrossRef
6.
go back to reference Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165–76.PubMedCrossRef Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165–76.PubMedCrossRef
8.
go back to reference Fontanella RA, Sideri S, Di Stefano C, Catizone A, Di Agostino S, Angelini DF, Guerrera G, Battistini L, Battafarano G, Del Fattore A, Campese AF, Padula F, De Cesaris P, Filippini A, Riccioli A. CD44v8–10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells. Cancer Biol Med. 2021;18(3):788–807. https://doi.org/10.20892/j.issn.2095-3941.2020.0495. Fontanella RA, Sideri S, Di Stefano C, Catizone A, Di Agostino S, Angelini DF, Guerrera G, Battistini L, Battafarano G, Del Fattore A, Campese AF, Padula F, De Cesaris P, Filippini A, Riccioli A. CD44v8–10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells. Cancer Biol Med. 2021;18(3):788–807. https://​doi.​org/​10.​20892/​j.​issn.​2095-3941.​2020.​0495.
9.
go back to reference An H, Tao N, Li J, Guan Y, Wang W, Wang Y, Wang F. Detection of prostate cancer metastasis by whole body magnetic resonance imaging combined with bone scintigraphy and PSA levels. Cell Physiol Biochem. 2016;40(5):1052–62.PubMedCrossRef An H, Tao N, Li J, Guan Y, Wang W, Wang Y, Wang F. Detection of prostate cancer metastasis by whole body magnetic resonance imaging combined with bone scintigraphy and PSA levels. Cell Physiol Biochem. 2016;40(5):1052–62.PubMedCrossRef
10.
11.
go back to reference Fornetti J, Welm AL, Stewart SA. Understanding the bone in cancer metastasis. J Bone Miner Res. 2018;33(12):2099–113.PubMedCrossRef Fornetti J, Welm AL, Stewart SA. Understanding the bone in cancer metastasis. J Bone Miner Res. 2018;33(12):2099–113.PubMedCrossRef
12.
go back to reference Luo G, He Y, Yu X. Bone marrow adipocyte: an intimate partner with tumor cells in bone metastasis. Front Endocrinol (Lausanne). 2018;9:339.PubMedCrossRef Luo G, He Y, Yu X. Bone marrow adipocyte: an intimate partner with tumor cells in bone metastasis. Front Endocrinol (Lausanne). 2018;9:339.PubMedCrossRef
13.
go back to reference Guerard A, Laurent V, Fromont G, Esteve D, Gilhodes J, Bonnelye E, Le Gonidec S, Valet P, Malavaud B, Reina N, Attane C, Muller C. The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes. Int J Mol Sci. 2021;22(4):1994. https://doi.org/10.3390/ijms22041994. Guerard A, Laurent V, Fromont G, Esteve D, Gilhodes J, Bonnelye E, Le Gonidec S, Valet P,  Malavaud B, Reina N, Attane C, Muller C. The Chemokine Receptor CCR3 Is Potentially Involved in the Homing of Prostate Cancer Cells to Bone: Implication of Bone-Marrow Adipocytes. Int J Mol Sci. 2021;22(4):1994. https://​doi.​org/​10.​3390/​ijms22041994.
15.
go back to reference Liu Z, Xu J, He J, Liu H, Lin P, Wan X, Navone NM, Tong Q, Kwak LW, Orlowski RZ, Yang J. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget. 2015;6(33):34329–41.PubMedPubMedCentralCrossRef Liu Z, Xu J, He J, Liu H, Lin P, Wan X, Navone NM, Tong Q, Kwak LW, Orlowski RZ, Yang J. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget. 2015;6(33):34329–41.PubMedPubMedCentralCrossRef
17.
go back to reference Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I. Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases. Cancer Metastasis Rev. 2014;33(2–3):527–43.PubMedPubMedCentralCrossRef Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I. Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases. Cancer Metastasis Rev. 2014;33(2–3):527–43.PubMedPubMedCentralCrossRef
18.
go back to reference Wang M, Chen Y, Xiong Z, Yu S, Zhou B, Ling Y, Zheng Z, Shi G, Wu Y, Qian X. Ginsenoside Rb1 inhibits free fatty acidsinduced oxidative stress and inflammation in 3T3L1 adipocytes. Mol Med Rep. 2017;16(6):9165–72.PubMedCrossRef Wang M, Chen Y, Xiong Z, Yu S, Zhou B, Ling Y, Zheng Z, Shi G, Wu Y, Qian X. Ginsenoside Rb1 inhibits free fatty acidsinduced oxidative stress and inflammation in 3T3L1 adipocytes. Mol Med Rep. 2017;16(6):9165–72.PubMedCrossRef
19.
go back to reference Zhang M, Wang C, Wu J, Ha X, Deng Y, Zhang X, Wang J, Chen K, Feng J, Zhu J, Xie J, Zhang J. The Effect and Mechanism of KLF7 in the TLR4/NF-kappaB/IL-6 Inflammatory Signal Pathway of Adipocytes. Mediators Inflamm. 2018;2018:1756494.PubMedPubMedCentralCrossRef Zhang M, Wang C, Wu J, Ha X, Deng Y, Zhang X, Wang J, Chen K, Feng J, Zhu J, Xie J, Zhang J. The Effect and Mechanism of KLF7 in the TLR4/NF-kappaB/IL-6 Inflammatory Signal Pathway of Adipocytes. Mediators Inflamm. 2018;2018:1756494.PubMedPubMedCentralCrossRef
20.
go back to reference Satapati S, Qian Y, Wu MS, Petrov A, Dai G, Wang SP, Zhu Y, Shen X, Muise ES, Chen Y, Zycband E, Weinglass A, Di Salvo J, Debenham JS, Cox JM, Lan P, Shah V, Previs SF, Erion M, Kelley DE, Wang L, Howard AD, Shang J. GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy. J Lipid Res. 2017;58(8):1561–78.PubMedPubMedCentralCrossRef Satapati S, Qian Y, Wu MS, Petrov A, Dai G, Wang SP, Zhu Y, Shen X, Muise ES, Chen Y, Zycband E, Weinglass A, Di Salvo J, Debenham JS, Cox JM, Lan P, Shah V, Previs SF, Erion M, Kelley DE, Wang L, Howard AD, Shang J. GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy. J Lipid Res. 2017;58(8):1561–78.PubMedPubMedCentralCrossRef
21.
go back to reference Huang WH, Xue YJ, Zhou YJ, Wu XG, Wu XX, Zhang XX, Dong XX, Wei YT. KLF7 promotes macrophage activation by activating the NF-kappaB signaling pathway in epicardial adipose tissue in patients with coronary artery disease. Eur Rev Med Pharmacol Sci. 2020;24(12):7002–14.PubMed Huang WH, Xue YJ, Zhou YJ, Wu XG, Wu XX, Zhang XX, Dong XX, Wei YT. KLF7 promotes macrophage activation by activating the NF-kappaB signaling pathway in epicardial adipose tissue in patients with coronary artery disease. Eur Rev Med Pharmacol Sci. 2020;24(12):7002–14.PubMed
22.
go back to reference Zhang Z, Wang H, Sun Y, Li H, Wang N. Klf7 modulates the differentiation and proliferation of chicken preadipocyte. Acta Biochim Biophys Sin (Shanghai). 2013;45(4):280–8.PubMedCrossRef Zhang Z, Wang H, Sun Y, Li H, Wang N. Klf7 modulates the differentiation and proliferation of chicken preadipocyte. Acta Biochim Biophys Sin (Shanghai). 2013;45(4):280–8.PubMedCrossRef
23.
go back to reference Wang C, Ha X, Li W, Xu P, Gu Y, Wang T, Wang Y, Xie J, Zhang J. Correlation of TLR4 and KLF7 in Inflammation Induced by Obesity. Inflammation. 2017;40(1):42–51.PubMedCrossRef Wang C, Ha X, Li W, Xu P, Gu Y, Wang T, Wang Y, Xie J, Zhang J. Correlation of TLR4 and KLF7 in Inflammation Induced by Obesity. Inflammation. 2017;40(1):42–51.PubMedCrossRef
24.
go back to reference Robinson T, Escara-Wilke J, Dai J, Zimmermann J, Keller ET. A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis. Prostate. 2023;83(13):1247–54.PubMedPubMedCentralCrossRef Robinson T, Escara-Wilke J, Dai J, Zimmermann J, Keller ET. A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis. Prostate. 2023;83(13):1247–54.PubMedPubMedCentralCrossRef
25.
go back to reference Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology. 2005;146(8):3622–31.PubMedCrossRef Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. Endocrinology. 2005;146(8):3622–31.PubMedCrossRef
26.
go back to reference Ha X, Wang J, Chen K, Deng Y, Zhang X, Feng J, Li X, Zhu J, Ma Y, Qiu T, Wang C, Xie J, Zhang J. Free fatty acids promote the development of prostate cancer by upregulating peroxisome proliferator-activated receptor gamma. Cancer Manag Res. 2020;12:1355–69.PubMedPubMedCentralCrossRef Ha X, Wang J, Chen K, Deng Y, Zhang X, Feng J, Li X, Zhu J, Ma Y, Qiu T, Wang C, Xie J, Zhang J. Free fatty acids promote the development of prostate cancer by upregulating peroxisome proliferator-activated receptor gamma. Cancer Manag Res. 2020;12:1355–69.PubMedPubMedCentralCrossRef
27.
go back to reference Wang C, Wang J, Chen K, Pang H, Li X, Zhu J, Ma Y, Qiu T, Li W, Xie J, Zhang J. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow. Cancer Sci. 2020;111(10):3600–12.PubMedPubMedCentralCrossRef Wang C, Wang J, Chen K, Pang H, Li X, Zhu J, Ma Y, Qiu T, Li W, Xie J, Zhang J. Caprylic acid (C8:0) promotes bone metastasis of prostate cancer by dysregulated adipo-osteogenic balance in bone marrow. Cancer Sci. 2020;111(10):3600–12.PubMedPubMedCentralCrossRef
28.
go back to reference Li X, Yuan C, Yang B, Pang H, Li W, Li M, Tang Y, Ma D, Xie J, Wang J, Zhang J. Caprylic Acid (FFA C8:0) promotes the progression of prostate cancer by up-regulating G protein-coupled receptor 84/ Kruppel-like factor 7. BMC Cancer. 2023;23(1):426.PubMedPubMedCentralCrossRef Li X, Yuan C, Yang B, Pang H, Li W, Li M, Tang Y, Ma D, Xie J, Wang J, Zhang J. Caprylic Acid (FFA C8:0) promotes the progression of prostate cancer by up-regulating G protein-coupled receptor 84/ Kruppel-like factor 7. BMC Cancer. 2023;23(1):426.PubMedPubMedCentralCrossRef
30.
go back to reference Zoni E, Minoli M, Bovet C, Wehrhan A, Piscuoglio S, Ng CKY, Gray PC, Spahn M, Thalmann GN, Kruithof-de Julio M. Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification. BMC Cancer. 2019;19(1):1216.PubMedPubMedCentralCrossRef Zoni E, Minoli M, Bovet C, Wehrhan A, Piscuoglio S, Ng CKY, Gray PC, Spahn M, Thalmann GN, Kruithof-de Julio M. Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification. BMC Cancer. 2019;19(1):1216.PubMedPubMedCentralCrossRef
31.
go back to reference Miranda M, Pino AM, Fuenzalida K, Rosen CJ, Seitz G, Rodriguez JP. Characterization of fatty acid composition in bone marrow fluid from postmenopausal women: modification after hip fracture. J Cell Biochem. 2016;117(10):2370–6.PubMedPubMedCentralCrossRef Miranda M, Pino AM, Fuenzalida K, Rosen CJ, Seitz G, Rodriguez JP. Characterization of fatty acid composition in bone marrow fluid from postmenopausal women: modification after hip fracture. J Cell Biochem. 2016;117(10):2370–6.PubMedPubMedCentralCrossRef
32.
go back to reference Frommer KW, Hasseli R, Schaffler A, Lange U, Rehart S, Steinmeyer J, Rickert M, Sarter K, Zaiss MM, Culmsee C, Ganjam G, Michels S, Muller-Ladner U, Neumann E. Free fatty acids in bone pathophysiology of rheumatic diseases. Front Immunol. 2019;10:2757.PubMedPubMedCentralCrossRef Frommer KW, Hasseli R, Schaffler A, Lange U, Rehart S, Steinmeyer J, Rickert M, Sarter K, Zaiss MM, Culmsee C, Ganjam G, Michels S, Muller-Ladner U, Neumann E. Free fatty acids in bone pathophysiology of rheumatic diseases. Front Immunol. 2019;10:2757.PubMedPubMedCentralCrossRef
33.
go back to reference Wang C, Zhang M, Wu J, Li W, Ha X, Gu Y, Han B, Xie J, Zhang J. The effect and mechanism of TLR9/KLF4 in FFA-Induced adipocyte inflammation. Mediators Inflamm. 2018;2018:6313484.PubMedPubMedCentralCrossRef Wang C, Zhang M, Wu J, Li W, Ha X, Gu Y, Han B, Xie J, Zhang J. The effect and mechanism of TLR9/KLF4 in FFA-Induced adipocyte inflammation. Mediators Inflamm. 2018;2018:6313484.PubMedPubMedCentralCrossRef
34.
35.
go back to reference McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90(4):1337–81.PubMedCrossRef McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90(4):1337–81.PubMedCrossRef
36.
go back to reference Jiang Z, Yu T, Fan Z, Yang H, Lin X. Kruppel-Like factor 7 is a marker of aggressive gastric cancer and poor prognosis. Cell Physiol Biochem. 2017;43(3):1090–9.PubMedCrossRef Jiang Z, Yu T, Fan Z, Yang H, Lin X. Kruppel-Like factor 7 is a marker of aggressive gastric cancer and poor prognosis. Cell Physiol Biochem. 2017;43(3):1090–9.PubMedCrossRef
37.
go back to reference Guan F, Kang Z, Zhang JT, Xue NN, Yin H, Wang L, Mao BB, Peng WC, Zhang BL, Liang X, Hu ZQ. KLF7 promotes polyamine biosynthesis and glioma development through transcriptionally activating ASL. Biochem Biophys Res Commun. 2019;514(1):51–7.PubMedCrossRef Guan F, Kang Z, Zhang JT, Xue NN, Yin H, Wang L, Mao BB, Peng WC, Zhang BL, Liang X, Hu ZQ. KLF7 promotes polyamine biosynthesis and glioma development through transcriptionally activating ASL. Biochem Biophys Res Commun. 2019;514(1):51–7.PubMedCrossRef
38.
go back to reference Ding X, Wang X, Gong Y, Ruan H, Sun Y, Yu Y. KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition. Oncol Lett. 2017;13(4):2281–9.PubMedPubMedCentralCrossRef Ding X, Wang X, Gong Y, Ruan H, Sun Y, Yu Y. KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition. Oncol Lett. 2017;13(4):2281–9.PubMedPubMedCentralCrossRef
39.
go back to reference Qiu T, Yang X, Wang J, Pan C, Chu X, Xiong J, Xie J, Chang Y, Wang C, Zhang J. Obesity-induced elevated palmitic acid promotes inflammation and glucose metabolism disorders through GPRs/NF-kappaB/KLF7 pathway. Nutr Diabetes. 2022;12(1):23.PubMedPubMedCentralCrossRef Qiu T, Yang X, Wang J, Pan C, Chu X, Xiong J, Xie J, Chang Y, Wang C, Zhang J. Obesity-induced elevated palmitic acid promotes inflammation and glucose metabolism disorders through GPRs/NF-kappaB/KLF7 pathway. Nutr Diabetes. 2022;12(1):23.PubMedPubMedCentralCrossRef
40.
go back to reference Zang J, Ma S, Wang C, Guo G, Zhou L, Tian X, Lv M, Zhang J, Han B. Screening for active constituents in Turkish galls against ulcerative colitis by mass spectrometry guided preparative chromatography strategy: in silico, in vitro and in vivo study. Food Funct. 2018;9(10):5124–38.PubMedCrossRef Zang J, Ma S, Wang C, Guo G, Zhou L, Tian X, Lv M, Zhang J, Han B. Screening for active constituents in Turkish galls against ulcerative colitis by mass spectrometry guided preparative chromatography strategy: in silico, in vitro and in vivo study. Food Funct. 2018;9(10):5124–38.PubMedCrossRef
41.
go back to reference Ma X, Hao M, Zhang MH, Zeng Y, Yang QQ, Zhao L, Fan CY, Ji ZH, Li KA, Li ZJ, Maimaiti M, Nie JH. Integrated strategy of network analysis prediction and experimental validation to elucidate the possible mechanism of compound Turkish gall ointment in treating eczema. Chin Med. 2022;17(1):89.PubMedPubMedCentralCrossRef Ma X, Hao M, Zhang MH, Zeng Y, Yang QQ, Zhao L, Fan CY, Ji ZH, Li KA, Li ZJ, Maimaiti M, Nie JH. Integrated strategy of network analysis prediction and experimental validation to elucidate the possible mechanism of compound Turkish gall ointment in treating eczema. Chin Med. 2022;17(1):89.PubMedPubMedCentralCrossRef
42.
go back to reference Zhang X, Zang J, Ma S, Yu W, Long F, Qi R, Guo G, Zhou L, Han B. Hollow microcapsules with ulcerative colitis therapeutic effects made of multifunctional Turkish galls extraction. ACS Appl Mater Interfaces. 2019;11(28):25054–65.PubMedCrossRef Zhang X, Zang J, Ma S, Yu W, Long F, Qi R, Guo G, Zhou L, Han B. Hollow microcapsules with ulcerative colitis therapeutic effects made of multifunctional Turkish galls extraction. ACS Appl Mater Interfaces. 2019;11(28):25054–65.PubMedCrossRef
43.
go back to reference Mun JG, Han YH, Jeon HD, Yoon DH, Lee YG, Hong SH, Kee JY. Inhibitory effect of gallotannin on lung metastasis of metastatic colorectal cancer cells by inducing apoptosis, cell cycle arrest and autophagy. Am J Chin Med. 2021;49(6):1535–55.PubMedCrossRef Mun JG, Han YH, Jeon HD, Yoon DH, Lee YG, Hong SH, Kee JY. Inhibitory effect of gallotannin on lung metastasis of metastatic colorectal cancer cells by inducing apoptosis, cell cycle arrest and autophagy. Am J Chin Med. 2021;49(6):1535–55.PubMedCrossRef
44.
go back to reference Kantapan J, Paksee S, Duangya A, Sangthong P, Roytrakul S, Krobthong S, Suttana W, Dechsupa N. A radiosensitizer, gallotannin-rich extract from Bouea macrophylla seeds, inhibits radiation-induced epithelial-mesenchymal transition in breast cancer cells. BMC Complement Med Ther. 2021;21(1):189.PubMedPubMedCentralCrossRef Kantapan J, Paksee S, Duangya A, Sangthong P, Roytrakul S, Krobthong S, Suttana W, Dechsupa N. A radiosensitizer, gallotannin-rich extract from Bouea macrophylla seeds, inhibits radiation-induced epithelial-mesenchymal transition in breast cancer cells. BMC Complement Med Ther. 2021;21(1):189.PubMedPubMedCentralCrossRef
45.
go back to reference Park E, Kwon HY, Jung JH, Jung DB, Jeong A, Cheon J, Kim B, Kim SH. Inhibition of Myeloid Cell Leukemia 1 and activation of caspases are critically involved in gallotannin-induced apoptosis in prostate cancer cells. Phytother Res. 2015;29(8):1225–36.PubMedCrossRef Park E, Kwon HY, Jung JH, Jung DB, Jeong A, Cheon J, Kim B, Kim SH. Inhibition of Myeloid Cell Leukemia 1 and activation of caspases are critically involved in gallotannin-induced apoptosis in prostate cancer cells. Phytother Res. 2015;29(8):1225–36.PubMedCrossRef
Metadata
Title
Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer
Authors
Jingzhou Wang
Jie Liu
Chenggang Yuan
Bingqi Yang
Huai Pang
Keru Chen
Jiale Feng
Yuchun Deng
Xueting Zhang
Wei Li
Cuizhe Wang
Jianxin Xie
Jun Zhang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-11826-5

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine